Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2024-11-22 00:00:00 ET · period of report 2024-11-22 · accession 0000950170-24-130255 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-22 | 2024-11-22 | DNA | SLOAN HARRY | Dir | J - Other | — | +4,222 | 828.0K | +0.5% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-11-22 | J | A | 4,222 | — | 828,025 | D | — | — | (F1) Shares received in a distribution from Eagle Equity Partners III-G LLC to its members |